PUF Ventures Inc. (CNSX:PUF) (Frankfurt: PU3) (OTCPK: PUFXF), and Cannvas Medtech Inc. (“MTEC”) are pleased to announce that on January 16, 2018 (the “Effective Date”), they completed a statutory arrangement under a plan of arrangement (the “Arrangement”).  As a result of completing the Arrangement, MTEC became a reporting issuer in the provinces of British ColumbiaAlberta and Ontario.

Completion of the Arrangement, as set forth in the arrangement agreement and plan of arrangement dated September 7, 2017, as amended on October 11, 2017 (the “Arrangement Agreement“), between PUF and Vapetronix Holdings Inc. (formerly, Weed Points Loyalty Inc., now Cannvas Medtech Inc.), was approved by the shareholders of PUF on November 24, 2017 and by a Final Order granted by the Supreme Court of British Columbia on November 30, 2017 in accordance with Part 9 of the Business Corporations Act (British Columbia).
Cannvas Medtech Inc.:
Pursuant to the Arrangement Agreement and on the Effective Date, the following occurred:


PUF distributed 100% of the common shares of MTEC (“MTECShares“) it received to the shareholders of PUF (the “PUFShareholders“) on a pro rata basis.  The PUF Shareholders received one MTEC Share in exchange for every seven (7) common shares of PUF held as at the Record Date, October 4, 2017;


PUF transferred the assets to MTEC;


MTEC became a reporting issuer in the Provinces of British Columbia, Alberta and Ontario; and


PUF retained its working capital for its assets, remains listed on the CSE and will continue to trade under the trading symbol, PUF, as a consumer products – biotechnology/pharmaceuticals company.

The CUSIP number for the common shares of MTEC is 13781A105.
As of the Effective Date, the board of directors of MTEC are Shawn MonizSteve Loutskou and Christopher P. Cherry and the officers of MTEC are Shawn Moniz, CEO, Steve Loutskou, Chief Strategy Officer and Secretary and Christopher P. Cherry, CFO.
“The executive team at Cannvas Medtech have been working very hard to identify additional opportunities within the cannabis industry and I am very pleased with the progress they have made to date,” said Derek Ivany, CEO of PUF Ventures. “The name change from Weed Points Loyalty was necessary due to core business opportunities expanding beyond the vertical integration within the cannabis industry. The new name better suits the company’s technology focused solutions for loyalty and all things cannabis with cross integration in the medical community. I am very confident at the prospects for our shareholders who have joined the Cannvas Medtech family of supporters and shareholders.”
About the Company
PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies: AAA Heidelberg, Solaris Nutraceuticals Pty Ltd., Cannvas MedTech Inc., and Natures Hemp Corp., and is actively pursuing other opportunities within the industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., a private Ontario company and advanced applicant for an ACMPR license. Currently, AAA Heidelberg has not received a license from Health Canada. PUF is publicly traded under the following symbols: CSE: PUF, Frankfurt: PU3 and OTCPK: PUFXF. For more information please visit: www.puf.ca.
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of the release.
Some of the statements contained in the release are forward-looking statements, such as estimates and statements that describe the Company’s future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur.  Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.

Subsequent to this press release, Cannvas MedTech went public on July 3, 2018 under the ticker symbol CSE:MTEC

Source: www.newswire.ca

Strong Innovation Pipeline Continues to Drive Market Share Growth
Broken Coast’s First Foray into Cannabis 2.0
Solei Introduces First Limited Release Vape on the Market
Solei, RIFF, Good Supply and B!NGO Expand Product Offerings

Aphria Inc. (” Aphria ” or the ” Company “) ( TSX: APHA and NASDAQ: APHA ), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, today announced the expansion of its 510 Vape offering across its award-winning adult-use brand portfolio.

Keep reading... Show less

Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”). If you wish to serve as lead plaintiff, you must move the Court before the December 1 2020 DEADLINE . A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=aurora-cannabis-inc&id=2437 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email info@zhanginvestorlaw.com for information on the class action.

Keep reading... Show less

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf Solutions“, “OILS”, or the “Company”), Canada’s most innovative cannabis extractor, is pleased to provide the following commercial and intellectual property update:

Cannabis Extraction Agreement with White Label Producer

Keep reading... Show less


Khiron Life Sciences Corp. (“ Khiron ” or, the “ Company ”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to announce that it has closed today its previously announced “bought deal” short form prospectus offering of units (“ Unit s ”), including the exercise in full of the over-allotment option (the “ Offering ”).

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, is scheduled to speak on a panel at the Cowen 2020 Boston Cannabis Conference on Wednesday, December 2, 2020 at 9:20 a.m. EST.

For more information regarding the Cowen 2020 Boston Cannabis Conference please visit: https://www.cowen.com/conferences-and-events/3rd-annual-boston-cannabis-conference/

Keep reading... Show less